These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2852051)

  • 1. Use of an established human hepatoma cell line with endogenous bioactivation for gene mutation studies.
    Chang G; Jacobson-Kram D; Williams JR
    Cell Biol Toxicol; 1988 Sep; 4(3):267-79. PubMed ID: 2852051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of 6-thioguanine-resistant mutations by rat-liver homogenate (S9)-activated promutagens in human embryonic skin fibroblasts.
    Chen DJ; Okinaka RT; Strniste GF; Barnhart BJ
    Mutat Res; 1982 Mar; 101(1):87-98. PubMed ID: 7078562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of an established rat hepatoma cell lime for mutation studies.
    Green HA; Kram D; Williams JR
    Mutat Res; 1982 Aug; 97(4):327-36. PubMed ID: 7121504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of HepG2 feeder cells generated by exposure to gamma-rays, X-rays, UV-C light or mitomycin C for ability to activate 7,12-dimethylbenz[a]anthracene in a cell-mediated Chinese hamster V79/HGPRT mutation assay.
    Schrader TJ
    Mutat Res; 1999 Jan; 423(1-2):137-48. PubMed ID: 10029691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two methods to induce 6-thioguanine resistance in human fibroblasts in the presence of rat-liver microsomes.
    Huang SL; Waters MD
    Mutat Res; 1983 Jul; 121(1):71-6. PubMed ID: 6408475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro induction, expression and selection of thioguanine-resistant mutants with human T-lymphocytes.
    O'Neill JP; Sullivan LM; Albertini RJ
    Mutat Res; 1990 Feb; 240(2):135-42. PubMed ID: 2300074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a human hepatoma cell line as a target cell in genetic toxicology.
    Dearfield KL; Jacobson-Kram D; Brown NA; Williams JR
    Mutat Res; 1983 Mar; 108(1-3):437-49. PubMed ID: 6682173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity, clastogenicity and cytotoxicity of procarcinogens in a rat hepatoma cell line competent for xenobiotic metabolism.
    Roscher E; Wiebel FJ
    Mutagenesis; 1988 May; 3(3):269-76. PubMed ID: 3045489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of liver cell cultures in mutagenesis studies.
    Huberman E; Jones CA
    Ann N Y Acad Sci; 1980; 349():264-72. PubMed ID: 6784635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the metabolic activation of 7, 12-dimethylbenz(a)anthracene by a human hepatoma cell line (HepG2) and low passage hamster embryo cells.
    DiGiovanni J; Singer JM; Diamond L
    Cancer Res; 1984 Jul; 44(7):2878-84. PubMed ID: 6327027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B1.
    Aoyama T; Yamano S; Guzelian PS; Gelboin HV; Gonzalez FJ
    Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4790-3. PubMed ID: 2162057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative forward-mutation specificity of mono-functional alkylating agents, ICR-191, and aflatoxin B1 in mouse lymphoma cells.
    MacInnes MA; Friedrich U; van Daalen Wetters T; Coffino P
    Mutat Res; 1982 Aug; 95(2-3):297-311. PubMed ID: 6289092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-mutagenicity of coumarin (1,2-benzopyrone) with aflatoxin B1 and human liver S9 in mammalian cells.
    Goeger DE; Hsie AW; Anderson KE
    Food Chem Toxicol; 1999 Jun; 37(6):581-9. PubMed ID: 10478826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promutagen activation by rodent-liver postmitochondrial fractions in the L5178Y/TK cell mutation assay.
    Amacher DE; Turner GN
    Mutat Res; 1980 Dec; 74(6):485-501. PubMed ID: 7464853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of 6-thioguanine-resistant lymphocytes in Fischer 344 rats following in vivo exposure to N-ethyl-N-nitrosourea and cyclophosphamide.
    Aidoo A; Lyn-Cook LE; Mittelstaedt RA; Heflich RH; Casciano DA
    Environ Mol Mutagen; 1991; 17(3):141-51. PubMed ID: 2022192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forward mutation assay of V79 cells to 6-thioguanine resistance in a soft agar technique that eliminates effects of metabolic co-operation.
    Nishi Y; Hasegawa MM; Inui N
    Mutat Res; 1984 Jan; 125(1):105-14. PubMed ID: 6690909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of mouse liver stored vitamin A on the induction of mutations (Ames tests) and SCE of bone marrow cells by aflatoxin B1, benzo(a)pyrene, or cyclophosphamide.
    Qin S; Huang CC
    Environ Mutagen; 1986; 8(6):839-47. PubMed ID: 3096708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some factors determining the concentration of liver proteins for optimal mutagenicity of chemicals in the Salmonella/microsome assay.
    Malaveille C; Kuroki T; Brun G; Hautefeuille A; Camus AM; Bartsch H
    Mutat Res; 1979 Dec; 63(2):245-58. PubMed ID: 392308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic analysis of aflatoxin B1 activation in rat hepatoma cells.
    Corcos L; Rousset JP; Kiefer F; Wiebel FJ; Weiss MC
    Mol Gen Genet; 1990 Jul; 222(2-3):291-6. PubMed ID: 2125692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenic responses of five independent genetic loci in CHO cells to a variety of mutagens. Development and characteristics of a mutagen screening system based on selection for multiple drug-resistant markers.
    Gupta RS; Singh B
    Mutat Res; 1982 Jun; 94(2):449-66. PubMed ID: 7110183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.